Goldman Sachs’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$212M Sell
3,250,292
-1,196,273
-27% -$80.9M 0.02% 694
2026
Q2
$285M Buy
4,446,565
+1,180,427
+36% +$77.6M 0.02% 615
2026
Q1
$232M Sell
3,266,138
-113,086
-3% -$8.92M 0.03% 611
2025
Q4
$277M Buy
3,379,224
+157,415
+5% +$12.3M 0.03% 507
2025
Q3
$242M Buy
3,221,809
+69,705
+2% +$5.2M 0.03% 531
2025
Q2
$233M Buy
3,152,104
+1,386,575
+79% +$96.5M 0.03% 513
2025
Q1
$142M Sell
1,765,529
-631,867
-26% -$54.3M 0.02% 629
2024
Q4
$187M Sell
2,397,396
-11,731
-0.5% -$997K 0.03% 528
2024
Q3
$226M Buy
2,409,127
+925,740
+62% +$77.7M 0.04% 471
2024
Q2
$116M Sell
1,483,387
-281,096
-16% -$22.9M 0.02% 727
2024
Q1
$160M Sell
1,764,483
-111,106
-6% -$9.24M 0.03% 573
2023
Q4
$145M Buy
1,875,589
+550,612
+42% +$38.6M 0.03% 603
2023
Q3
$90.2M Buy
1,324,977
+277,682
+27% +$20.2M 0.02% 770
2023
Q2
$85.1M Sell
1,047,295
-53,503
-5% -$4.27M 0.02% 789
2023
Q1
$90.3M Sell
1,100,798
-461,571
-30% -$33M 0.02% 744

Other funds holding GEHC

Goldman Sachs's GEHC Position: Q3 2026 in Review

Goldman Sachs reduced its GE HealthCare (GEHC) stake by 27% in Q3 2026, selling an estimated $80.9M and leaving 3,250,292 shares worth $212M. The position accounts for 0.02% of the portfolio, ranked #694.

Goldman Sachs first reported a position in GEHC in Q1 2023 and has held it in 15 quarters since. The position peaked at $285M in Q2 2026. 1,225 funds tracked by Wall St. Rank hold GEHC as of Q3 2026.

  • Goldman Sachs held 3,250,292 shares of GE HealthCare worth $212M as of Q3 2026.
  • Goldman Sachs sold 1,196,273 GE HealthCare shares in Q3 2026, an estimated $80.9M.
  • GE HealthCare made up 0.02% of Goldman Sachs's portfolio in Q3 2026, its #694 holding.
  • Goldman Sachs first reported a position in GE HealthCare in Q1 2023 and has held it in 15 quarters since.
  • Goldman Sachs's GE HealthCare position peaked at $285M in Q2 2026.
  • 1,225 funds tracked by Wall St. Rank held GE HealthCare as of Q3 2026.

Based on Goldman Sachs's 13F filing for Q3 2026, filed 16 Nov 2026.